DROSHA FUNCTION

德罗莎功能

基本信息

  • 批准号:
    8169135
  • 负责人:
  • 金额:
    $ 2.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-01 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. MicroRNAs are small non-coding regulatory RNAs implicated in both development and cancer. MicroRNA precursors are processed by Microprocessor, a complex consisting of the endonuclease drosha and its partner, the DGCR8 protein. Drosha is also part of another larger nuclear complex, hereafter called Macroprocessor. Macroprocessor contains several RNA binding and unwinding factors as well as EWS, an RNA-binding protein involved in human tumors, but its function and the identities of its substrates are unknown. I intend to characterize the Macroprocessor complex and identify its substrates. In order to study drosha?s function, I have previously employed retroviral siRNA-producing vectors to reduce drosha protein levels in HeLa cells, and found that knockdown cells show reduced viability by a colony formation assay. Rnt1, the sole RNAse III in budding yeast, has several mRNA substrates. To determine if drosha, too, has a role in mRNA processing, I conducted an expression analysis of the knockdowns using microarrays. There were a total of 44 probe sets identified, 17 of which increased in the drosha knockdowns, and 27 of which decreased. One of the 27 targets that decreased (c-jun) was identified with two different probe sets. Another decreasing target in all four comparisons was, as expected, the drosha mRNA itself. None of the targets (except drosha) display homology to any of the siRNA constructs, making it unlikely that they are off-target effects. I am building on my substantial body of preliminary data, capitalizing on my unique and powerful reagents (the affinity-purified anti-drosha antibody and the anti-drosha siRNA knockdown constructs), as well as the extensive biochemical and mass spectrometric resources of the Chait lab to characterize the role of drosha in the Macroprocessor complex. Thus far I have isolated and identified several drosha substrates/interactors and determined some aspects of drosha's dynamics within the cell cycle.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 MicroRNA是一种小的非编码调节RNA,与发育和癌症有关。MicroRNA前体由微处理器处理,微处理器是由内切核酸酶drosha及其伴侣DGCR 8蛋白组成的复合物。Drosha也是另一个更大的核复合体的一部分,以下称为Macroprocessor。宏处理器包含多种RNA结合和解旋因子以及EWS(一种参与人类肿瘤的RNA结合蛋白),但其功能及其底物的身份尚不清楚。我打算描述宏处理器复合体的特征并确定其基质。为了研究德罗沙?为了研究Drosha的功能,我以前曾使用逆转录病毒siRNA生产载体来降低HeLa细胞中的Drosha蛋白水平,并通过集落形成试验发现敲低的细胞显示出降低的生存力。 Rnt 1是芽殖酵母中唯一的RNA酶III,具有几种mRNA底物。为了确定drosha是否也在mRNA加工中发挥作用,我使用微阵列对敲除进行了表达分析。总共鉴定了44个探针组,其中17个在drosha敲除中增加,27个减少。用两种不同的探针组鉴定了减少的27个靶标之一(c-jun)。正如预期的那样,在所有四个比较中,另一个下降的目标是drosha mRNA本身。没有一个靶标(除了drosha)显示出与任何siRNA构建体的同源性,使得它们不太可能是脱靶效应。 我正在建立我的大量初步数据,利用我独特而强大的试剂(亲和纯化的抗drosha抗体和抗drosha siRNA敲低构建体),以及Chait实验室广泛的生化和质谱资源来表征drosha在Macroprocessor复合物中的作用。到目前为止,我已经分离并鉴定了几种drosha底物/相互作用物,并确定了drosha在细胞周期中的动力学的某些方面。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERICA Y JACOBS其他文献

ERICA Y JACOBS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERICA Y JACOBS', 18)}}的其他基金

YEAST RDNA PROJECT
酵母RDNA项目
  • 批准号:
    8361514
  • 财政年份:
    2011
  • 资助金额:
    $ 2.91万
  • 项目类别:
DROSHA FUNCTION
德罗莎功能
  • 批准号:
    8361515
  • 财政年份:
    2011
  • 资助金额:
    $ 2.91万
  • 项目类别:
YEAST RDNA PROJECT
酵母RDNA项目
  • 批准号:
    8169134
  • 财政年份:
    2010
  • 资助金额:
    $ 2.91万
  • 项目类别:
YEAST RDNA PROJECT
酵母RDNA项目
  • 批准号:
    7954094
  • 财政年份:
    2009
  • 资助金额:
    $ 2.91万
  • 项目类别:
DROSHA FUNCTION
德罗莎功能
  • 批准号:
    7954095
  • 财政年份:
    2009
  • 资助金额:
    $ 2.91万
  • 项目类别:
DROSHA FUNCTION
德罗莎功能
  • 批准号:
    7722240
  • 财政年份:
    2008
  • 资助金额:
    $ 2.91万
  • 项目类别:
YEAST RDNA PROJECT
酵母RDNA项目
  • 批准号:
    7722239
  • 财政年份:
    2008
  • 资助金额:
    $ 2.91万
  • 项目类别:
Isolation and Characterization of Yeast rDNA Chromatin
酵母 rDNA 染色质的分离和表征
  • 批准号:
    7274254
  • 财政年份:
    2006
  • 资助金额:
    $ 2.91万
  • 项目类别:
Isolation and Characterization of Yeast rDNA Chromatin
酵母 rDNA 染色质的分离和表征
  • 批准号:
    7155837
  • 财政年份:
    2006
  • 资助金额:
    $ 2.91万
  • 项目类别:
DROSHA FUNCTION
德罗莎功能
  • 批准号:
    7355137
  • 财政年份:
    2006
  • 资助金额:
    $ 2.91万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 2.91万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 2.91万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 2.91万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 2.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了